These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 7796668)
1. The role of superantigens in the immunobiology of retroviruses. Huber BT; Beutner U; Subramanyam M Ciba Found Symp; 1994; 187():132-40; discussion 140-3. PubMed ID: 7796668 [TBL] [Abstract][Full Text] [Related]
2. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. Beutner U; Kraus E; Kitamura D; Rajewsky K; Huber BT J Exp Med; 1994 May; 179(5):1457-66. PubMed ID: 8163931 [TBL] [Abstract][Full Text] [Related]
3. The role of superantigens in virus infection. Huber BT J Clin Immunol; 1995 Nov; 15(6 Suppl):22S-25S. PubMed ID: 8613488 [TBL] [Abstract][Full Text] [Related]
5. Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss. Barnett A; Mustafa F; Wrona TJ; Lozano M; Dudley JP J Virol; 1999 Aug; 73(8):6634-45. PubMed ID: 10400761 [TBL] [Abstract][Full Text] [Related]
6. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains. Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017 [TBL] [Abstract][Full Text] [Related]
7. Mouse mammary tumor virus superantigens require N-linked glycosylation for effective presentation to T cells. McMahon CW; Bogatzki LY; Pullen AM Virology; 1997 Feb; 228(2):161-70. PubMed ID: 9123822 [TBL] [Abstract][Full Text] [Related]
8. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen. Wrona TJ; Lozano M; Binhazim AA; Dudley JP J Virol; 1998 Jun; 72(6):4746-55. PubMed ID: 9573239 [TBL] [Abstract][Full Text] [Related]
9. MHC class II hierarchy of superantigen presentation predicts efficiency of infection with mouse mammary tumor virus. Held W; Waanders GA; MacDonald HR; Acha-Orbea H Int Immunol; 1994 Sep; 6(9):1403-7. PubMed ID: 7819149 [TBL] [Abstract][Full Text] [Related]
10. Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus. Held W; Shakhov AN; Izui S; Waanders GA; Scarpellino L; MacDonald HR; Acha-Orbea H J Exp Med; 1993 Feb; 177(2):359-66. PubMed ID: 8093892 [TBL] [Abstract][Full Text] [Related]
11. Expression of a MHC class II transgene determines both superantigenicity and susceptibility to mammary tumor virus infection. Pucillo C; Cepeda R; Hodes RJ J Exp Med; 1993 Oct; 178(4):1441-5. PubMed ID: 8397273 [TBL] [Abstract][Full Text] [Related]
12. Mouse mammary tumor viruses with functional superantigen genes are selected during in vivo infection. Golovkina TV; Dudley JP; Jaffe AB; Ross SR Proc Natl Acad Sci U S A; 1995 May; 92(11):4828-32. PubMed ID: 7761408 [TBL] [Abstract][Full Text] [Related]
16. B and T cells are required for mouse mammary tumor virus spread within the mammary gland. Golovkina TV; Dudley JP; Ross SR J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233 [TBL] [Abstract][Full Text] [Related]
17. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus. Hodes RJ; Novick MB; Palmer LD; Knepper JE J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408 [TBL] [Abstract][Full Text] [Related]